Replies to post #114836 on Biotech Values

[DewDiligence]

ViiV (i.e. GSK for all practical purposes) starts phase-3 trial of Selzentry+Prezista vs Truvada+Prezista:

http://finance.yahoo.com/news/ViiV-Healthcare-Starts-Phase-prnews-2842047759.html?x=0&.v=1

Selzentry is called ‘Censentri’ in Europe.